VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
PRQR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
PRQRProQR Therapeutics N.V.
$1.15$116M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksPRQRP/E History

PRQR logoProQR Therapeutics N.V. (PRQR) P/E Ratio History

Insufficient Data

Insufficient historical P/E data to classify valuation. · Data 2026–2026

Current P/E (TTM)
-2.6x
5Y Avg P/E
N/A
Median N/A
5Y Percentile
N/A
PEG Ratio
N/A
TTM EPS$-0.39
Price$1.10
Earnings YieldN/A
EPS Growth (1Y)-11.8%
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

As of November 18, 2026, ProQR Therapeutics N.V. (PRQR) trades at a price-to-earnings ratio of -2.6x, with a stock price of $1.10 and trailing twelve-month earnings per share of $-0.39.

Compared to the Healthcare sector median P/E of 24.7x, PRQR trades at a 111% discount to its sector peers. The sector includes 252 companies with P/E ratios ranging from 0.0x to 187.0x.

Relative to the broader market, PRQR trades at a notable discount to the S&P 500 median P/E of 21.7x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our PRQR DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

PRQR Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Healthcare
-2.6vs24.7
-111%
Below Sector
vs. S&P 500
-2.6vs21.7
-112%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on -12% EPS growth (1Y)
Consensus & Technical Research Suite
Open PRQR Terminal

PRQR Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

PRQR — Frequently Asked Questions

Quick answers to the most common questions about buying PRQR stock.

What is PRQR's P/E ratio?

ProQR Therapeutics N.V. (PRQR) trailing twelve-month P/E ratio is -2.6x, based on TTM diluted EPS of $-0.39. The 5-year average P/E is N/A and the historical range spans N/A to N/A.

Is PRQR stock overvalued or undervalued?

PRQR current P/E: -2.6x. 5-year average P/E: N/A. Percentile: N/A.

Is PRQR stock expensive?

PRQR is fairly valued relative to its own history. The current P/E of -2.6x is near the 5-year average of N/A (N/A percentile of historical range).

What is PRQR's historical P/E range?

Over the past 5 years, PRQR's P/E ratio has ranged from N/A to N/A, with a median of N/A and an average of N/A. The current P/E of -2.6x places the stock at the N/A percentile of this range. Full historical data spans 2026–2026.

How does PRQR's P/E compare to the S&P 500?

PRQR trades at -2.6x P/E versus the S&P 500 median of 21.7x. The 112% discount to the market suggests lower growth expectations or perceived higher risk.

How does PRQR's valuation compare to Healthcare peers?

ProQR Therapeutics N.V. P/E of -2.6x compares to the Healthcare sector median of 24.7x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.

What is PRQR's PEG ratio?

PRQR PEG ratio is N/A, based on a P/E of -2.6x and EPS growth of -11.8%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is PRQR's earnings yield?

PRQR earnings yield is N/A, the inverse of its -2.6x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

PRQR P/E Ratio History

Quarterly valuation multiple from closing price and trailing EPS

Current-
Period Avg-
Range- - -
Change-
0 quarters- - -